We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
–
AUM
$1.28B
AUM Growth
+$52.4M
Cap. Flow
+$14.6M
Cap. Flow %
1.14%
Top 10 Hldgs %
76.61%
Holding
30
New
–
Increased
4
Reduced
24
Closed
2

Top Buys

Rank Stock Value
1
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$62.2M
2
MTCH icon
Match Group
MTCH
+$12M
3
DFS
Discover Financial Services
DFS
+$9.79M
4
PM icon
Philip Morris
PM
+$6.07M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.79M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.26M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.45M
4
IBKR icon
Interactive Brokers
IBKR
+$3.89M
5
FCNCA icon
First Citizens BancShares
FCNCA
+$2.98M

Sector Composition

Rank Sector Weight
1 Financials 25.2%
2 Communication Services 21.65%
3 Healthcare 12.69%
4 Consumer Discretionary 10.48%
5 Consumer Staples 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.36T
$183M 14.31%
1,003,523
-58,054
-5% -$9.79M
REGN icon
2
Regeneron Pharmaceuticals
REGN
$78.5B
$147M 11.47%
139,454
-5,619
-4% -$5.45M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.1T
$139M 10.86%
341,033
-20,207
-6% -$8.26M
IBKR icon
4
Interactive Brokers
IBKR
$39.2B
$99.3M 7.77%
3,239,196
-130,504
-4% -$3.89M
IJR icon
5
iShares Core S&P Small-Cap ETF
IJR
$109B
$96.5M 7.55%
904,478
+581,689
+180% +$62.2M
AMZN icon
6
Amazon
AMZN
$2.92T
$74.1M 5.8%
383,277
-15,442
-4% -$2.84M
PINS icon
7
Pinterest
PINS
$13.4B
$59.5M 4.66%
1,350,583
-54,415
-4% -$2.15M
PM icon
8
Philip Morris
PM
$297B
$55.1M 4.31%
543,543
+62,039
+13% +$6.07M
HIBB
9
DELISTED
Hibbett, Inc. Common Stock
HIBB
$52.8M 4.13%
605,382
-3,850
-0.6% -$319K
DFS
10
DELISTED
Discover Financial Services
DFS
$42.7M 3.34%
326,594
+78,535
+32% +$9.79M
FCNCA icon
11
First Citizens BancShares
FCNCA
$24.9B
$41.2M 3.23%
24,500
-1,780
-7% -$2.98M
IBB icon
12
iShares Biotechnology ETF
IBB
$9.34B
$37.4M 2.93%
272,443
-10,977
-4% -$1.47M
MTCH icon
13
Match Group
MTCH
$9.19B
$34.3M 2.69%
1,130,236
+379,031
+50% +$12M
CTVA icon
14
Corteva
CTVA
$52.6B
$32M 2.51%
593,303
-23,904
-4% -$1.32M
HLF icon
15
Herbalife
HLF
$1.29B
$28M 2.19%
2,696,608
-108,645
-4% -$1.09M
GHC icon
16
Graham Holdings Company
GHC
$5.1B
$15.1M 1.18%
21,537
-868
-4% -$634K
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$121B
$9.29M 0.73%
19,819
-798
-4% -$346K
RAMP icon
18
LiveRamp
RAMP
$2.3B
$7.85M 0.61%
253,597
-69,192
-21% -$2.22M
BBWI icon
19
Bath & Body Works
BBWI
$4.06B
$7.03M 0.55%
179,925
-7,249
-4% -$333K
BNTX icon
20
BioNTech
BNTX
$22.9B
$6.21M 0.49%
77,292
-3,114
-4% -$285K
SQM icon
21
Sociedad Química y Minera de Chile
SQM
$19.2B
$5.67M 0.44%
139,215
-5,609
-4% -$259K
MDLZ icon
22
Mondelez International
MDLZ
$79.5B
$4.2M 0.33%
64,194
-2,586
-4% -$177K
RSKD icon
23
Riskified
RSKD
$694M
$3.09M 0.24%
483,194
-19,468
-4% -$110K
GIS icon
24
General Mills
GIS
$19.1B
$1.37M 0.11%
21,615
-22,471
-51% -$1.54M
CTMX icon
25
CytomX Therapeutics
CTMX
$675M
– –
-906,157
Closed -$1.98M
1
2

Similar funds

EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Bronte Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Bronte Capital Management held 30 positions worth $1.28B, up 4.3% from $1.23B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Bronte Capital Management's Q2 2024 filing shows 4 increased, 24 reduced and 2 closed positions. The largest sale was Alphabet (Google) Class A, an estimated $9.79M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Communication Services and Healthcare.

  • Bronte Capital Management added most to iShares Core S&P Small-Cap ETF in Q2 2024, an estimated $62.2M increase.
  • Bronte Capital Management's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $9.79M.
  • Bronte Capital Management fully exited CytomX Therapeutics in Q2 2024, selling an estimated $1.98M.
  • Bronte Capital Management's ten largest holdings make up 77% of its $1.28B portfolio in Q2 2024.
  • Bronte Capital Management opened 0 new positions and closed 2 in Q2 2024.
  • Bronte Capital Management's portfolio value rose 4.3% quarter-over-quarter to $1.28B.

Based on Bronte Capital Management's 13F filing for Q2 2024, filed 7 Aug 2024.